Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Peptide: Support Healthy Cellular Aging
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri senolytic human trial FOXO4 -DRI (10MG)INJECTION, Packaging Type: Vial at ₹ 3200/piece in Nagpur